Search
Search
Eyewire News: The Podcast
12.24.25
There were several advancements made during the first 6 months of 2025, including the first FDA approval for neurodegenerative disease MacTel; the approval of a first-of-its-kind drug for dry eye disease; advancements in premium IOLs; the approval of an excimer laser platform, and the launch of a new presbyopia drop. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
12.31.25
2025 Year in Review - Part 212.24.25
2025 Year in Review - Part 112.17.25
Update on Reproxalap PDUFA Timing11.18.25
Live Coverage of B+L Investor DayShow More
